Lilly says Mounjaro and Zepbound sales more than doubled as stock ralliesBy Mario Cazombo / February 4, 2026 Late last year, Lilly was the first pharmaceutical stock to reach a $1 trillion valuation.
Book Review: The Financial Restructuring Tool Set August 6, 2025 / Book Reviews, Corporate Finance, Drivers of Value, Economics, Financial Statement Analysis, General
